The effectiveness of vaccination with whole-cell pertussis vaccine by age group in Poland 1996-2001

被引:8
作者
Zielinski, A [1 ]
Rosinska, M [1 ]
Czarkowski, M [1 ]
Rudowska, J [1 ]
机构
[1] Natl Inst Hyg, Dept Epidemiol, PL-00791 Warsaw, Poland
关键词
D O I
10.1080/00365540310018897
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Recurrence of pertussis in highly vaccinated populations has been observed in many countries. Two mechanisms have been proposed to explain it: a shift in incidence towards older age groups in which the protective effect of vaccination is diminished; and vaccine-induced changes in genomic and immunological characteristics of circulating strains of Bordetella pertussis, which become different from vaccine strains, thereby reducing vaccine efficacy. Marked increase in the incidence of pertussis has been observed in Poland since 1997, following a decade of stability at a low level. As previously shown, the immunization calendar in Poland does not ensure sufficient protection among children older than 9 y. The decrease in the protective effect becomes noticeable after the age of 5. In this paper we examine changes in the effectiveness of pertussis vaccination in 4 age groups during 1996 - 2001, using surveillance data. We find that over that period a decrease occurred in the reported effectiveness ( in children aged 2 to 5 y, from 97.3% in 1996 to 73.5% in 2001 and in 6 to 9 y-olds, from 84.3% to 68.8%). We also discuss an alternative hypothesis that the above findings are due to selection or measurement bias resulting from incomplete reporting or imperfect diagnostic procedures.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 19 条
[11]   Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands:: Temporal trends and evidence for vaccine-driven evolution [J].
Mooi, FR ;
van Oirschot, H ;
Heuvelman, K ;
van der Heide, HGJ ;
Gaastra, W ;
Willems, RJL .
INFECTION AND IMMUNITY, 1998, 66 (02) :670-675
[12]   Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine [J].
Olin, P ;
Gustafsson, L ;
Barreto, L ;
Hessel, L ;
Mast, TC ;
Van Rie, A ;
Bogaerts, H ;
Storsaeter, J .
VACCINE, 2003, 21 (17-18) :2015-2021
[13]   ASSESSING VACCINE EFFICACY IN THE FIELD - FURTHER OBSERVATIONS [J].
ORENSTEIN, WA ;
BERNIER, RH ;
HINMAN, AR .
EPIDEMIOLOGIC REVIEWS, 1988, 10 :212-241
[14]   AGE-SPECIFIC EFFICACY OF PERTUSSIS-VACCINE DURING EPIDEMIC AND NONEPIDEMIC PERIODS [J].
RAMSAY, MEB ;
FARRINGTON, CP ;
MILLER, E .
EPIDEMIOLOGY AND INFECTION, 1993, 111 (01) :41-48
[15]   The changing age and seasonal profile of pertussis in Canada [J].
Skowronski, DM ;
De Serres, G ;
MacDonald, D ;
Wu, W ;
Shaw, C ;
Macnabb, J ;
Champagne, S ;
Patrick, DM ;
Halperin, SA .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (10) :1448-1453
[16]  
Slusarczyk Janusz, 2002, Przegl Epidemiol, V56, P39
[17]   Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998 [J].
Siranda Torvaldsen ;
Judy M. Simpson ;
Peter B. McIntyre .
European Journal of Epidemiology, 2003, 18 (1) :63-69
[18]   Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population [J].
van Loo, IHM ;
van der Heide, HGJ ;
Nagelkerke, NJD ;
Verhoef, J ;
Mooi, FR .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :915-923
[19]  
Zielinski A, 2001, Przegl Epidemiol, V55, P207